21 – 30 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Minimal clinically important differences in average, best, worst and current intensity and unpleasantness of chronic breathlessness
- Contribution to journal › Article
-
Mark
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality : A nationwide cohort study of the global SABINA programme
- Contribution to journal › Article
- 2019
-
Mark
Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPD
- Contribution to journal › Article
- 2018
-
Mark
Missed opportunity? Worsening breathlessness as a harbinger of death : A cohort study
- Contribution to journal › Article
-
Mark
Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension
- Contribution to journal › Article
- 2017
-
Mark
Risk of pulmonary embolism and deep venous thrombosis in patients with asthma : A nationwide case-control study from Sweden
- Contribution to journal › Article
-
Mark
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits
- Contribution to journal › Article
-
Mark
Incident opioid drug use and adverse respiratory outcomes among older adults with COPD
- Contribution to journal › Letter
-
Mark
LSC - 2017 - Hippo-YAP/TAZ signaling is deranged in IPF
- Contribution to journal › Published meeting abstract
-
Mark
European Respiratory Society statement : Diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency
- Contribution to journal › Article
